Atlas Trials

PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

Clinical trial NCT02985801 · TERMINATED

Trial details

NCT number
NCT02985801
Sponsor
Massimo Raimondo, M.D.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic InsufficiencyPancreatic CancerPancreatic Enzyme Abnormality
Start date
2016-12-01
Primary completion
2019-04-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.